Assessment of Airway Obstruction in Infants With Lower Respiratory Infections

Completed · Not applicable

Conditions studied: Bronchiolitis, Respiratory Syncytial Virus Infections

In brief

The purpose of this study is to evaluate how two different aerosol medications may improve airway function in infants with respiratory illness. We are using two different medications and comparing the difference in lung function after each medication. We will also be taking a nasal wash sample for VEGF. We will be using this in comparing how infants respond to the aerosol medications as well. We hope to help standardize medications used for infants with bronchiolitis and RSV.

Key facts

Study ID

NCT00435994

Run by

Indiana University

People needed

59

Starts

2003-12-01

Expected to finish

2012-12-01

Last updated by the study team

2016-06-01

Who can join

Age: 0 and older, up to 2. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Group 1 Infants between 2 and 24 months that are healthy
• Group 2 Infants between 2 and 24 months that have RSV or bronchiolitis and defined as the first episode of wheezing

You may not qualify if…

• Group 1 and 2 - no cardiac disease, no oxygen requirement, prematurity < 37 weeks, and cannot be in the ICU.

Where it is running

• Riley Hospital for Children — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.